| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |